NeuroPace (NASDAQ:NPCE) Stock Quotes, Forecast and News Summary

Q: What sector and industry does NeuroPace (NPCE) operate in?

NeuroPace is in the Health Care sector and Health Care Equipment & Supplies industry. They are listed on the NASDAQ.

NeuroPace Stock (NASDAQ: NPCE) stock price, news, charts, stock research, profile.

Open	$7.32
Close	$6.81
Volume / Avg.	46.45K / 138.15K
Day Range	6.77 - 7.37
52 Wk Range	3.91 - 18.15
Market Cap	$195.91M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	40
Short Interest	0.64%
Days to Cover	1.21

Recent News

Epilepsy-Focused MedTech NeuroPace Has Attractive Entry Point, Competitive Position

Cantor Fitzgerald initiated coverage on NeuroPace Inc (NASDAQ: NPCE), a commercial-stage medical device company focused on drug-resistant epilepsy treatment through the company's responsive neurostimulation device (RNS).

Vandana Singh

Top 5 Health Care Stocks That May Fall Off A Cliff

The most overbought stocks in the health care sector presents an opportunity to go short on these overvalued companies.

Lisa Levin

Why Alpha Tau Medical Shares Are Trading Higher By Over 8%; Here Are 20 Stocks Moving Premarket

Gainers Tivic Health Systems, Inc. (NASDAQ: TIVC) rose 62.4% to $3.15 in pre-market trading after falling 11% on Monday. Tivic Health Systems inked a pact to make its products available on AmerisourceBergen’s third-party marketplace.

Lisa Levin

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Jan

Feb

Mar

May

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.0

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

About NeuroPace Inc

Sector

Health Care

Industry

Health Care Equipment & Supplies

NeuroPace Inc is a commercial-stage medical device company focused on transforming the lives of peop...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy NeuroPace (NPCE) stock?

You can purchase shares of NeuroPace (NASDAQ:NPCE) through any online brokerage.

View our list of the best stock brokerages

Who are NeuroPace (NPCE) competitors?

Other companies in NeuroPace’s space includes: Axogen (NASDAQ:AXGN), Sight Sciences (NASDAQ:SGHT), Semler Scientific (NASDAQ:SMLR), AngioDynamics (NASDAQ:ANGO) and Fractyl Health (NASDAQ:GUTS).

What is the target price for NeuroPace (NPCE) stock?

There is no analysis for NeuroPace.

What is the forecast for NeuroPace (NPCE) stock?

NeuroPace has a consensus price target of $17.00.

Current stock price for NeuroPace (NPCE)?

The stock price for NeuroPace (NASDAQ: NPCE) is $6.81 last updated Today at July 8, 2024 at 4:00 PM EDT.

Does NeuroPace (NPCE) pay a dividend?

There are no upcoming dividends for NeuroPace.

When is NeuroPace (NASDAQ:NPCE) reporting earnings?

NeuroPace’s Q2 earnings are confirmed for Tuesday, August 6, 2024.

Is NeuroPace (NPCE) going to split?

There is no upcoming split for NeuroPace.

What sector and industry does NeuroPace (NPCE) operate in?

NeuroPace is in the Health Care sector and Health Care Equipment & Supplies industry. They are listed on the NASDAQ.

-

-

-

-

-

-

-

-

-

-

-

-

-

-

NeuroPace

NeuroPace (NPCE) Forecast